Sci. Signal., 25 March 2008
Medicine Faulty Scaffolding and Cancer
Paula A. Kiberstis
Science, AAAS, Washington, DC 20005, USA
Differentiation, survival, and growth of B cells requires proper functioning of the nuclear factor B (NF-B) signaling pathway, including CARD11, a cytoplasmic scaffolding protein that serves as a docking site for signaling molecules. Lenz et al. have discovered that a certain subtype of diffuse large B cell lymphoma (DLBCL), the most common form of non-Hodgkins lymphoma in humans, is caused by mutations in the CARD11 gene. In cell culture experiments, these mutant forms of CARD11 caused inappropriate activation of the NF-B pathway.
G. Lenz, R. E. Davis, V. N. Ngo, L. Lam, T. C. George, G. W. Wright, S. S. Dave, H. Zhao, W. Xu, A. Rosenwald, G. Ott, H. K. Muller-Hermelink, R. D. Gascoyne, J. M. Connors, L. M. Rimsza, E. Campo, E. S. Jaffe, J. Delabie, E. B. Smeland, R. I. Fisher, W. C. Chan, L. M. Staudt, Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676-1679 (2008). [Abstract] [Full Text]
Citation: P. A. Kiberstis, Faulty Scaffolding and Cancer. Sci. Signal. 1, ec113 (2008).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882